BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Authors
» Douglas Merrill
Douglas Merrill
Articles
ARTICLES
Germany's Neuer Markt Closing Amid Mounting Losses, Scandals
Sep. 30, 2002
By
Douglas Merrill
Germany's Neuer Markt Closing Amid Mounting Losses, Scandals
Sep. 30, 2002
By
Douglas Merrill
Cardion Closes EUR10M Financing To Fund CRB-15, Stem Cell Work
Sep. 25, 2002
By
Douglas Merrill
Zentaris, Access Oncology Enter $30M Alliance For Cancer Drug
Sep. 25, 2002
By
Douglas Merrill
Cardion Closes EUR10M Financing To Fund CRB-15, Stem Cell Work
Sep. 25, 2002
By
Douglas Merrill
Zentaris, Access Oncology Enter $30M Alliance For Cancer Drug
Sep. 25, 2002
By
Douglas Merrill
Cenix BioScience Raises EUR5M To Develop RNAi Technology
Sep. 18, 2002
By
Douglas Merrill
Cenix BioScience Raises EUR5M To Develop RNAi Technology
Sep. 18, 2002
By
Douglas Merrill
MediGene Reports Positive Early Results In Liver Cancer
Sep. 11, 2002
By
Douglas Merrill
MediGene Reports Positive Early Results In Liver Cancer
Sep. 11, 2002
By
Douglas Merrill
View All Articles by Douglas Merrill
